The International Vaccine Institute (IVI), EuBiologics, and DEK Vaccines Limited (DEK) signs a memorandum of understanding (MoU) for the fill and finish of oral cholera vaccine in Ghana.
Through this partnership DEK will be authorized to purchase, locally fill and finish, and distribute the oral cholera vaccine. As at July 2023, the WHO Regional Office for Africa (AFRO) data revealed an estimated 211, 643 cholera cases and 3, 953 deaths have been recorded in the region.
''I'm very happy with this partnership with IVI and EuBiologics through which we are going to make oral cholera vaccine in Accra, Ghana to supply Africa, and we hope to do this with typhoid conjugate vaccine as well. This partnership has been very important because it's bringing technology to Africa, and we hope that we can continue to work closely with IVI and participate in technology transfer so that we can spread it across Africa for the benefit of Africans,'' said Dr. Kofi Nsiah-Poku, the Managing Director, DEK, Accra, Ghana.
For more information on this report visit here.
The Inocul8 Team
Preventive-health writers and clinicians sharing trustworthy vaccine guidance for Nigeria.
The Human Papillomavirus (HPV) vaccine is one of the most effective tools for preventing cervical cancer . In Nigeria, where cervical cancer remains one…
Hantavirus is a rare but serious disease that has gained global attention because it can cause severe lung and kidney problems. Although infections are…
Hepatitis A and Hepatitis B are both viral infections that affect the liver, but they spread differently, cause different long-term health risks, and…
Book a vaccination or a free consultation today — at your home, office, or an access point near you.